Scientific Expertise and Education  

• Pipeline Mastery at Scale: Build and continuously maintain deep knowledge of AstraZeneca’s cell therapy pipeline across multiple indications and assets.  

• Recognized Thought Leadership: Establish and sustain highest-level scientific and medical expertise in cell therapy; recognized internally and externally as a go-to expert, shaping guidance, training, and best practices for assigned protocols and sites 

• Strategic Portfolio Communication: Lead site-facing and expert stakeholder communications that clearly convey AstraZeneca’s cell therapy strategy, portfolio breadth, and product differentiation; ensure consistent, compliant messaging across regions. 

• Initiative Ownership and Execution: Design, lead, and implement high-impact local initiatives with trialists and key experts to support R&D or study implementation, aligned with GPT, Global R&D, and Country Medical Affairs; track outcomes and scale successful approaches. 

• Education Gap Identification and Closure: Systematically assess educational needs across owned sites, deliver advanced protocol training, and escalate patterns to Global Clinical Development with recommendations for enterprise-level solutions. 

• Insight Generation and Influence: Capture, synthesize, and deliver actionable field insights (feasibility, operational bottlenecks, patient pathways) to global and local stakeholders; drive early risk identification and influence protocol/process adjustments. 

Clinical Trial Support 

• Advanced Education and Readiness: Lead delivery of SIV content; provide advanced protocol education and competency-based staff training to ensure readiness, compliance, and consistency across sites and indications. Drive patient selection quality, safety management, and site-specific action plans; deliver measurable improvements in start-up timelines and protocol adherence 

• Recruitment and Retention Performance: Implement targeted protocol education (e.g., inclusion/exclusion criteria application etc.) to uplift enrolment rates, reduce screen failures, and minimize attrition. 

• Issue Triage, Escalation, and Risk Mitigation: Serve as the primary field point for protocol and clinical issues; triage and escalate appropriately, drive root-cause analysis, and implement corrective/preventive actions to reduce deviations and data queries. 

• Structured, Compliant Scientific Exchange: Lead timely, high-quality scientific and medical communications with trialists and internal partners, ensuring alignment with compliance policies and legal requirements; standardize messaging and capture learnings for reuse. 

• Insight Loop and Continuous Improvement: Systematically capture site-level insights; synthesize trends for study teams and cross-functional stakeholders, influencing protocol/process adjustments and scaling proven practices. 

 Operational  

• Cross-functional orchestration: Lead coordinated delivery with CTCO Functions, Clinical Development, Medical Affairs, Supply/Logistics, Patient Operations and Country Ops to ensure rapid, reliable service to internal stakeholders and study sites. 

• Portfolio coverage and resiliency: Provide proactive coverage for other FCAs and high-priority sites; implement standardized playbooks to maintain continuity of operations during surges, vacations, or escalations. 

• Regulatory and policy stewardship: Maintain current knowledge of local regulations, guidelines, codes of practice, and AstraZeneca policies relevant to Clinical Development; translate requirements into practical site actions and support inspection readiness. 

• External scientific engagement: Attend and contribute at relevant scientific meetings and conferences; synthesize takeaways into concise briefs and recommendations for study teams and operational processes. 

• Innovation sourcing and scaling: Build relationships with industry leaders and ecosystem partners; identify, pilot, and scale innovations (e.g., workflow tools, logistics optimizations, patient support solutions) that improve cycle times, quality, and site experience. 

Cross Functional 

• Global workstreams: Provide country specific field insights and subject-matter expertise to priority global initiatives; review/shape core strategies and deliverables to enable scalable, locally compliant adoption. 

• Medical Affairs: Partner on scientific strategy, congress/education plans, and field content; ensure accuracy, balance, and governance compliance across materials and training. 

• Commercial (within governance): Coordinate through approved interfaces to align on market dynamics and objectives 

• Evidence and insights: Elevate actionable field signals to inform global research strategy and lifecycle plans; ensure traceability from signal to decision. 

• Governance: Operate within AZ policies/SOPs and local regulations 

Impact 

• Operational velocity and quality: Directly improve speed, quality, and consistency of AstraZeneca’s cell therapy trials—reducing cycle times, elevating protocol adherence, and accelerating patient access to innovative treatments.

Education, Qualifications, Skills and Experience

Essential

• Education: Bachelor’s degree in a health-related field required; advanced degree (PharmD, PhD, MSc, NP/PA, MD/RN) preferred.